DARA Profile
DARA Biosciences, Inc. (DARA) was a biopharmaceutical company that focused on developing and commercializing oncology and oncology-support products. The company was founded in 2001 and was headquartered in Morrisville, North Carolina.
DARA's product pipeline included a range of oncology and oncology-support products, including treatments for breast cancer, leukemia, and multiple myeloma. Its solutions were designed to improve patient outcomes and quality of life, and to address the unmet medical needs of cancer patients.
In 2015, DARA Biosciences merged with Midatech Pharma PLC, a pharmaceutical company based in the United Kingdom. The merger was aimed at combining DARA's oncology and oncology-support products with Midatech's drug delivery technologies and expertise, and at creating a stronger, more diversified biopharmaceutical company.
As a result of the merger, DARA Biosciences, Inc. is no longer a publicly traded company. However, its legacy continues through its contributions to the development of oncology and oncology-support products, and through the many patients who have benefited from its solutions over the years. The merger also provided DARA shareholders with the opportunity to participate in the growth of Midatech Pharma as a leading provider of drug delivery technologies and solutions serving the biopharmaceutical industry.
|
